Werewolf Thera

$13.70 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Werewolf Thera

Werewolf Therapeutics, Inc. operates as an oncology biotherapeutics company. The Company develops novel immuno-stimulatory therapeutics and medicines for the treatment of cancer diseases. Werewolf Therapeutics in the State of Massachusetts.

Stock Analysis

last close $13.7
1-mo return -14.4%
3-mo return -26.3%
avg daily vol. 65.24T
52-week high 23.99
52-week low 11.23
market cap. $413M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $--
inst own. 78.8%

Subscribe now for daily local and international financial news